KAYA (Nova Pharmaceuticals Australasia Pty Ltd)
Product name
KAYA
Date registered
Evaluation commenced
Decision date
Approval time
120 (255 working days)
Active ingredients
drospirenone, ethinylestradiol
Registration type
New generic medicine
Indication
TRADENAME is indicated for use as an oral contraceptive.